Scholars Central

Conference abstractPublished 29 Feb 2016

Pharmacological activities of 3-iodothyronamine (T1AM) and 3-iodothyroacetic acid (TA1), two among the end metabolites of Thyroid hormone

Authors: Laura Raimondi, Annunzitina Laurino

University of Florence, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

3-iodothyronamine (T1AM) is a trace amine derived from Thyroid hormone metabolism circulating in rodents and humans whose physiological role remains to be discovered. Much is instead known on T1AM pharmacological effects even if the the mechanism(s) responsible for such effects are only partially exploited. T1AM pharmacodynamics features include interaction at trace amine receptors (subtypes 1-3-8), alfa2 and b2 adrenergic receptors. Interestingly, at alfa-2 and TAAR8 the amine behaves as an inverse agonist. More recently, T1AM was reported as a modulator of TRPM8, thus suggesting T1AM as a multi-target molecule and as a possible modulator of G-protein coupled receptors. Accordingly, we have recently described T1AM as an antagonist at muscarinic type 3 receptor. In the last years we have been involved in exploiting pharmacological effects of T1AM low doses in mice. In recent years we have our results suggest T1AM has the potential to behave as a neuromediator of the histaminergic signaling. In particular we found that the amine is able to modify mice behavior including feeding, learning and memory, pain threshold. All these effects were due, at least in part, to the production of its oxidative metabolite, the TA1. Interstingly enough, the TA1/T1AM endogenous levels averaging 1.7% is maintained also after pharmacological administration of T1AM. All the effects of T1AM and of TA1so far studied are mediated by the release of histamine. Our data indicate the existence of a novel network connecting the Thyroid with histamine. Furthermore, accumulation of T1AM and/or TA1 may account for the histaminergic and antimuscarinic effects observed in Thyroid patients including itch, hyperalgesia and disturbances of sleep/arousal cycle.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Thyroid Disorders & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Thyroid Disorders & Therapy
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Laura Raimondi”
  • BylineArticles whose byline prints “Annunzitina Laurino”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels